Blai Coll, M.D., Ph.D.

Blai Coll, M.D., Ph.D.

Chief Medical OfficeratStructure Therapeutics· In proxies 2024–2025

Pay in FY2025-6% from the year before · Structure Therapeutics stock +156.5% the same year

Blai Coll, M.D., Ph.D. was paid $3.2M in FY2025 (Dec), down 6%. Structure Therapeutics stock rose 156.5% that year.

Pay$100 in the stock at the end of FY23 → $171
Pay is from the Summary Compensation Table of each Structure Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Structure TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role -40%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?